Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study

Abstract Over the last two decades, the frontline therapy for mantle cell lymphoma (MCL) has evolved. However, the impact of subsequent lines of therapy on survival outcomes has not been well characterized. In this study, we investigated the treatment patterns and survival outcomes in patients with...

Full description

Bibliographic Details
Main Authors: Allison M. Bock, Jennifer J. Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema K. Tawfiq, Seth Maliske, Matthew J. Maurer, Brian F. Kabat, Jonas Paludo, David J. Inwards, Sabarish Ayyappan, Brian K. Link, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Umar Farooq, Yucai Wang
Format: Article
Language:English
Published: Nature Publishing Group 2023-11-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00942-3